USH2A and Usher syndrome: The use of patient-derived retinal organoids, which have already been generated for Usher syndrome caused by USH2A mutations,147,148 will further aid in the testing of novel treatments by providing the opportunity to demonstrate therapeutic potential in retinal-specific cells in vitro.